Maito, Nasheed A.

HRN: 27-59-19  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/10/2026
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
03/10/2026
03/17/2026
IV
30mg
Q8hours
PCAP-C
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines